Skip to main content

Technique reveals proteins moving as they work

Researchers at Weill Cornell Medicine have shown the ability to record the high-speed motions of proteins while correlating their motion to function, which should allow scientists to study proteins in greater detail than ever before.

New EARS model aims to broaden peer support across campus

Cornell’s nearly 50-year-old Empathy, Assistance and Referral Service (EARS) will begin offering a new model of support this fall, including peer mentoring, training and outreach.

Dr. Geraldine McGinty appointed senior associate dean for clinical affairs

Dr. Geraldine McGinty, an esteemed clinical operations strategist, administrator and radiologist, has been appointed senior associate dean for clinical affairs at Weill Cornell Medicine, effective Sept. 1.

Around Cornell

Red blood cell alterations contribute to lupus

The autoimmune disease lupus may be triggered by a defective process in the development of red blood cells (RBCs), according to a study led by researchers at Weill Cornell Medicine. The discovery could lead to new methods for classifying and treating patients with this disease.

Researchers reveal new suicide prevention tools from survivors

Lessons from suicide survivors – people who, despite the urge to die, find ways to cope and reasons to live – are seldom heard, but Cornell researchers and their colleagues have written one of the first studies to change that.

Food scientists create national atlas for deadly listeria

The pathogen listeria soon may become easier to track down in food recalls, thanks to a new genomic and geological mapping tool created by Cornell food scientists.

Cancer vaccine improves outcomes in Lynch syndrome model

A new strategy for developing vaccines against cancer showed promise in a proof-of-concept study led by scientists at Weill Cornell Medicine, NewYork-Presbyterian and Heidelberg University Hospital.

Geographic differences in gut microbiota boost immunity

Cornell researchers “humanized” mice with microbiota from three global populations and found that microbial differences alone can impact immune responses.

Dog DNA startup announces $75M in venture funding

Embark Veterinary, Inc. – a canine genetics startup company that graduated from Cornell’s McGovern Center incubator in late 2017 – announced $75 million in venture funding on July 26.